Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Lew

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 1, 1995
Antifungal Prophylaxis in Severely Neutropenic Patients: How Much Fluconazole is Necessary?Christian Van Delden, Daniel P. Lew, Bernard Chapuis, et al.
Trends in Microbiology|December 17, 2009
Exploring innate glycopeptide resistance mechanisms in Staphylococcus aureusAdriana Renzoni, William L Kelley, Pierre Vaudaux, et al.
The Journal of Antimicrobial Chemotherapy|May 31, 2003
Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureusPierre Vaudaux, Patrice Francois, Carmelo Bisognano, et al.
Antimicrobial Agents and Chemotherapy|June 16, 2010
Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureusPierre Vaudaux, Elzbieta Huggler, Louis Bernard, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Intensive therapy with ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant Staphylococcus aureusPierre Vaudaux, Asllan Gjinovci, Manuela Bento, et al.
International Journal of Antimicrobial Agents|March 19, 2011
Extracellular and intracellular bactericidal activities of XF-70 against small-colony variant hemB mutants of meticillin-susceptible and meticillin-resistant Staphylococcus aureusPierre Vaudaux, Elzbieta Huggler, William Rhys-Williams, et al.
International Journal of Antimicrobial Agents|September 12, 2009
Comparative activity of oritavancin against meticillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates from Geneva University HospitalPierre Vaudaux, Elzbieta Huggler, Francis F Arhin, et al.
Intensive Care Medicine|November 26, 2002
Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontaminationJorge Garbino, Daniel P Lew, Jacques-A Romand, et al.
Antimicrobial Agents and Chemotherapy|April 15, 2009
Comparison of tigecycline and vancomycin for treatment of experimental foreign-body infection due to methicillin-resistant Staphylococcus aureusPierre Vaudaux, Bénédicte Fleury, Asllan Gjinovci, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2012
The posttranslocational chaperone lipoprotein PrsA is involved in both glycopeptide and oxacillin resistance in Staphylococcus aureusAmbre Jousselin, Adriana Renzoni, Diego O Andrey, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 1, 1995
Antifungal Prophylaxis in Severely Neutropenic Patients: How Much Fluconazole is Necessary?Christian Van Delden, Daniel P. Lew, Bernard Chapuis, et al.
Trends in Microbiology|December 17, 2009
Exploring innate glycopeptide resistance mechanisms in Staphylococcus aureusAdriana Renzoni, William L Kelley, Pierre Vaudaux, et al.
The Journal of Antimicrobial Chemotherapy|May 31, 2003
Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureusPierre Vaudaux, Patrice Francois, Carmelo Bisognano, et al.
Antimicrobial Agents and Chemotherapy|June 16, 2010
Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureusPierre Vaudaux, Elzbieta Huggler, Louis Bernard, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Intensive therapy with ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant Staphylococcus aureusPierre Vaudaux, Asllan Gjinovci, Manuela Bento, et al.
International Journal of Antimicrobial Agents|March 19, 2011
Extracellular and intracellular bactericidal activities of XF-70 against small-colony variant hemB mutants of meticillin-susceptible and meticillin-resistant Staphylococcus aureusPierre Vaudaux, Elzbieta Huggler, William Rhys-Williams, et al.
International Journal of Antimicrobial Agents|September 12, 2009
Comparative activity of oritavancin against meticillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates from Geneva University HospitalPierre Vaudaux, Elzbieta Huggler, Francis F Arhin, et al.
Intensive Care Medicine|November 26, 2002
Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontaminationJorge Garbino, Daniel P Lew, Jacques-A Romand, et al.
Antimicrobial Agents and Chemotherapy|April 15, 2009
Comparison of tigecycline and vancomycin for treatment of experimental foreign-body infection due to methicillin-resistant Staphylococcus aureusPierre Vaudaux, Bénédicte Fleury, Asllan Gjinovci, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2012
The posttranslocational chaperone lipoprotein PrsA is involved in both glycopeptide and oxacillin resistance in Staphylococcus aureusAmbre Jousselin, Adriana Renzoni, Diego O Andrey, et al.
Pageof 4